Celgene CEO on deal to acquire Impact Biomedicines

Celgene CEO Mark Alles on the company's acquisition of Impact Biomedicines and the future of biotech and drug innovation.

(Source: Fox Business TV, January 9, 2018 at 10:50AM)

Recommended posts powered by Google